Lyngby, Denmark

Klaus Nyegaard Kristiansen


Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1999-2001

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Klaus Nyegaard Kristiansen: Innovator in Antibiotic Production

Introduction

Klaus Nyegaard Kristiansen is a notable inventor based in Lyngby, Denmark. He has made significant contributions to the field of antibiotic production, particularly in the development of processes involving β-lactam antibiotics. With a total of 3 patents to his name, Kristiansen's work has had a considerable impact on biotechnology.

Latest Patents

Kristiansen's latest patents focus on the biosynthesis of β-lactam antibiotics. One of his key inventions is a process for producing β-lactam antibiotics by applying micro-organisms with increased ligase activity. This invention not only outlines the methods for producing these antibiotics in vivo and in vitro but also introduces a novel enzyme that catalyzes specific steps in β-lactam biosynthesis. Additionally, the patent includes a DNA construct encoding this novel enzyme, along with a recombinant vector or transformation vehicle that incorporates the DNA construct, and a cell that contains either the DNA construct or the recombinant vector.

Career Highlights

Throughout his career, Klaus Nyegaard Kristiansen has worked with prominent companies in the biotechnology sector, including Gist-Brocades N.V. and Novo Nordisk A/S. His experience in these organizations has contributed to his expertise in antibiotic production and biotechnological innovations.

Collaborations

Kristiansen has collaborated with several professionals in his field, including Svend Kaasgaard and Michi Egel-Mitani. These collaborations have likely enhanced his research and development efforts in antibiotic biosynthesis.

Conclusion

Klaus Nyegaard Kristiansen is a distinguished inventor whose work in the production of β-lactam antibiotics has advanced the field of biotechnology. His innovative approaches and collaborations continue to influence antibiotic research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…